6-[4-[5-fluoro-2-(4-methylpyrimidin-5-yl)-3-pyridinyl]piperazin-1-yl]-2-methyl-2-azaspiro[3.4]octane
C22H29FN6 — CID 171092466
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[4-[5-fluoro-2-(4-methylpyrimidin-5-yl)-3-pyridinyl]piperazin-1-yl]-2-methyl-2-azaspiro[3.4]octane
6-[4-[5-fluoro-2-(4-methylpyrimidin-5-yl)-3-pyridinyl]piperazin-1-yl]-2-methyl-2-azaspiro[3.4]octane (PubChem CID 171092466) has the molecular formula C22H29FN6 and a molecular weight of 396.51 g/mol. Its IUPAC name is 6-[4-[5-fluoro-2-(4-methylpyrimidin-5-yl)-3-pyridinyl]piperazin-1-yl]-2-methyl-2-azaspiro[3.4]octane.
Molecular Properties
| Compound Name | 6-[4-[5-fluoro-2-(4-methylpyrimidin-5-yl)-3-pyridinyl]piperazin-1-yl]-2-methyl-2-azaspiro[3.4]octane |
|---|---|
| PubChem CID | 171092466 |
| Molecular Formula | C22H29FN6 |
| Molecular Weight | 396.51 g/mol |
| Exact Mass | 396.24 |
| IUPAC Name | 6-[4-[5-fluoro-2-(4-methylpyrimidin-5-yl)-3-pyridinyl]piperazin-1-yl]-2-methyl-2-azaspiro[3.4]octane |
| SMILES | Cc1ncncc1-c1ncc(F)cc1N1CCN(C2CCC3(C2)CN(C)C3)CC1 |
| InChI | InChI=1S/C22H29FN6/c1-16-19(12-24-15-26-16)21-20(9-17(23)11-25-21)29-7-5-28(6-8-29)18-3-4-22(10-18)13-27(2)14-22/h9,11-12,15,18H,3-8,10,13-14H2,1-2H3 |
| InChIKey | HPNSRMYVTWBFCS-UHFFFAOYSA-N |
| XLogP | 2.59 |
| TPSA | 48.39 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 396.51 |
| LogP ≤ 5 | 2.59 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171092466 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.